A Phase 1 Randomized, Placebo-Controlled, Blinded, Multiple Ascending Dose Study to Evaluate VIB 7734 in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren¿s
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Viela Bio, Inc.
Start Date
July 16, 2019
End Date
May 11, 2021
Administered By
Dermatology
Awarded By
Viela Bio, Inc.
Start Date
July 16, 2019
End Date
May 11, 2021